0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > 4-1BB

4-1BB

4-1BB Molecule Information

Name:Tumor necrosis factor receptor superfamily member 9
Target Synonym:Tumor necrosis factor receptor superfamily member 9?T-cell antigen ILA?CD_antigen=CD137?ILA?TNFRSF9?CDw137?CD137 ?T-cell antigen 4-1BB homolog?4-1BB ligand receptor
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:5
Lastest Research Phase:Phase ?

4-1BB Protein Product ListCompare or Buy

Cat. No. Species Product Description Structure Purity Feature
41B-H522a Human Human 4‑1BB / TNFSF9 Protein, low endotoxin
41B-H522a-structure
41B-H522a-sds
41B-H522a-elisa_1
41B-H5256 Human Human 4-1BB / TNFRSF9 Protein, Mouse IgG2a Fc Tag, low endotoxin
41B-H5256-structure
41B-H5256-sds
41B-H5256-elisa_1
41B-H82E3 Human Biotinylated Human 4-1BB / TNFRSF9 Protein, His Tag, Avi Tag (Avitag™)
41B-H82E3-structure
41B-H82E3-sds
41B-H82E3-elisa_1
41B-H82F7 Human Biotinylated Human 4-1BB /TNFRSF9, Fc Tag, Avi Tag (Avitag™)
41B-H82F7-structure
41B-H82F7-sds
41B-H82F7-elisa_1
41B-M52H7 Mouse Mouse 4-1BB / TNFRSF9 Protein
41B-M52H7-structure
41B-M52H7-sds
41B-M52H7-elisa_1
41B-M5258 Mouse Mouse 4-1BB /TNFRSF9 Protein, Fc Tag
41B-M5258-structure
41B-M5258-sds
41B-M5258-elisa_1
41B-C52H4 Cynomolgus Cynomolgus / Rhesus macaque 4-1BB / TNFRSF9 Protein
41B-C52H4-structure
41B-C52H4-sds
41B-C52H4-elisa_1
41B-H5258 Human Human 4-1BB / TNFRSF9 Protein, Fc Tag
41B-H5258-structure
41B-H5258-sds
41B-H5258-elisa_1
41B-H5227 Human Human 4‑1BB / TNFSF9 Protein, His Tag
41B-H5227-structure
41B-H5227-sds
41B-H5227-elisa_1

4-1BB Molecule Synonym Name

TNFRSF9,4-1BB,CD137,CDw137,ILA

4-1BB Molecule Background

4-1BB is also known as CD137, tumor necrosis factor receptor superfamily member 9 (TNFRSF9), induced by lymphocyte activation (ILA), is a co-stimulatory molecule of the tumor necrosis factor (TNF) receptor superfamily. CD137 can be expressed by activated T cells, but to a larger extent on CD8 than on CD4 T cells. In addition, CD137 expression is found on dendritic cells, follicular dendritic cells, natural killer cells, granulocytes and cells of blood vessel walls at sites of inflammation. The best characterized activity of CD137 is its costimulatory activity for activated T cells. Crosslinking of CD137 enhances T cell proliferation, IL-2 secretion survival and cytolytic activity. Further, it can enhance immune activity to eliminate tumors in mice. CD137 can enhance activation-induced T cell apoptosis when triggered by engagement of the TCR/CD3 complex. In addition, 4-1BB/4-1BBL co-stimulatory pathway has been shown to augment secondary CTL responses to several viruses, and meanwhile augment anti-tumor immunity. 4-1BB thus is a promising candidate for immunotherapy of human cancer. CD137 has been shown to interact with TRAF2.

4-1BB References

4-1BB Related Molecule

4-1BB Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
ADG-106 ADG-106 Phase Ⅰ Adagene Solid tumours, Non-Hodgkin's lymphoma (NHL) Details
Utomilumab PF-05082566; PF-2566; PF-5082566,PF05082566; PF2566; PF5082566 Phase Ⅱ Pfizer, MorphoSys Solid tumours, Colorectal cancer, Non-Hodgkin's lymphoma (NHL) Details
LOAd-703 LOAd-703,LOAd 703,LOAd703 Phase Ⅱ Uppsala University, Lokon Pharma Colorectal cancer, Ovarian cancer, Pancreatic cancer, Biliary cancer Details
Urelumab BMS-663513; BMS-66513 ,BMS663513,BMS-66513 Phase Ⅱ Bristol-Myers Squibb, Ono Pharmaceutical B-cell lymphoma, Chronic lymphocytic leukemia (CLL), Solid tumours, Multiple myeloma (MM), Colorectal cancer, Head and neck cancer Details
PRS-343 PRS-343,PRS 343,PRS343 Phase Ⅰ Pieris Pharmaceuticals Solid tumours Details

This web search service is supported by Google Inc.

totop